{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:48:10Z","timestamp":1777520890750,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2415-13-69","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T12:01:26Z","timestamp":1383912086000},"source":"Crossref","is-referenced-by-count":27,"title":["Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance"],"prefix":"10.1186","volume":"13","author":[{"given":"Nikitas","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Labiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Aristeidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Tentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Kortsaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios P","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"359_CR1","first-page":"166","volume-title":"General Ophthalmology, Los Altos","author":"D Vaughn","year":"1980","unstructured":"Vaughn D, Asbury T: General Ophthalmology, Los Altos. 1980, Calif.: Lange Medical Publications, 166-175."},{"key":"359_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0014-4835(92)90151-H","volume":"54","author":"O Maepea","year":"1992","unstructured":"Maepea O, Bill A: Pressures in the juxtacanalicular tissue and Schlemm\u2019s canal in monkeys. Exp Eye Res. 1992, 54: 879-883. 10.1016\/0014-4835(92)90151-H.","journal-title":"Exp Eye Res"},{"issue":"4","key":"359_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exer.2005.10.011","volume":"82","author":"M Johnson","year":"2006","unstructured":"Johnson M: What controls aqueous humour outflow resistance. Exp Eye Res. 2006, 82 (4): 545-557. 10.1016\/j.exer.2005.10.011.","journal-title":"Exp Eye Res"},{"key":"359_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/exer.2002.1144","volume":"74","author":"CR Ethier","year":"2002","unstructured":"Ethier CR: The inner wall of Schlemm\u2019scanal. Exp Eye Res. 2002, 74: 161-172. 10.1006\/exer.2002.1144.","journal-title":"Exp Eye Res"},{"key":"359_CR5","first-page":"21","volume":"75","author":"JM Potau","year":"2000","unstructured":"Potau JM, Canals M, Costa J, Merindano MD, Ruano D: Ultrastructural characteristics of glaucomatous trabecular meshwork. Arch Soc Esp Oftalmol. 2000, 75: 21-28.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2005.02.008","volume":"81","author":"E Lutjen-Drecoll","year":"2005","unstructured":"Lutjen-Drecoll E: Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res. 2005, 81: 1-4. 10.1016\/j.exer.2005.02.008.","journal-title":"Exp Eye Res"},{"issue":"1","key":"359_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/02713683.2011.622849","volume":"37","author":"YZ Shoshani","year":"2012","unstructured":"Shoshani YZ, Harris A, Shoja MM, Rusia D, Siesky B, Arieli Y, Wirostko B: Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma. Curr Eye Res. 2012, 37 (1): 1-11. 10.3109\/02713683.2011.622849.","journal-title":"Curr Eye Res"},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archopht.123.4.458","volume":"123","author":"SC Sacca","year":"2005","unstructured":"Sacca SC, Pascotto A, Camicione P, et al: Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005, 123: 458-463. 10.1001\/archopht.123.4.458.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"359_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ajo.2006.01.047","volume":"141","author":"U Schl\u00f6tzer-Schrehardt","year":"2006","unstructured":"Schl\u00f6tzer-Schrehardt U, Naumann GO: Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006, 141 (5): 921-937. 10.1016\/j.ajo.2006.01.047.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"359_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1350-9462(02)00014-9","volume":"22","author":"R Ritch","year":"2003","unstructured":"Ritch R, Schl\u00f6tzer-Schrehardt U, Konstas AG: Why is glaucoma associated with exfoliation syndrome?. ProgRetin Eye Res. 2003, 22 (3): 253-275.","journal-title":"ProgRetin Eye Res"},{"key":"359_CR11","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem. 1999, 274: 21491-21494. 10.1074\/jbc.274.31.21491.","journal-title":"J Biol Chem"},{"issue":"8","key":"359_CR12","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1096\/fasebj.5.8.1850705","volume":"5","author":"JF Woessner Jr","year":"1991","unstructured":"Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5 (8): 2145-2154.","journal-title":"FASEB J"},{"issue":"8","key":"359_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003, 92 (8): 827-839. 10.1161\/01.RES.0000070112.80711.3D.","journal-title":"Circ Res"},{"key":"359_CR14","doi-asserted-by":"publisher","first-page":"17119","DOI":"10.1074\/jbc.271.29.17119","volume":"271","author":"H Will","year":"1996","unstructured":"Will H, Atkinson SJ, Butler GS, Smith B, Murphy G: The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation: regulation by TIMP-2 and TIMP-3. J Biol Chem. 1996, 271: 17119-17123. 10.1074\/jbc.271.29.17119.","journal-title":"J Biol Chem"},{"issue":"13","key":"359_CR15","first-page":"2514","volume":"39","author":"AF Clark","year":"1998","unstructured":"Clark AF: New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci. 1998, 39 (13): 2514-2516.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"359_CR16","first-page":"2649","volume":"39","author":"JM Bradley","year":"1998","unstructured":"Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, Samples JR, Acott TS: Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998, 39 (13): 2649-2658.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"359_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1167\/iovs.02-0365","volume":"44","author":"U Schl\u00f6tzer-Schrehardt","year":"2003","unstructured":"Schl\u00f6tzer-Schrehardt U, Lommatzsch J, K\u00fcchle M, Konstas AG, Naumann GO: Matrixmetalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome\/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003, 44 (3): 1117-1125. 10.1167\/iovs.02-0365.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"359_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.ijg.0000145812.39224.0a","volume":"14","author":"M M\u00e4\u00e4tt\u00e4","year":"2005","unstructured":"M\u00e4\u00e4tt\u00e4 M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H, Sorsa T: Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma. 2005, 14 (1): 64-69. 10.1097\/01.ijg.0000145812.39224.0a.","journal-title":"J Glaucoma"},{"issue":"35","key":"359_CR19","doi-asserted-by":"publisher","first-page":"31240","DOI":"10.1074\/jbc.M502641200","volume":"280","author":"X Zhou","year":"2005","unstructured":"Zhou X, Li F, Kong L, Tomita H, Li C, Cao W: Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. JBiol Chem. 2005, 280 (35): 31240-31248. 10.1074\/jbc.M502641200.","journal-title":"JBiol Chem"},{"key":"359_CR20","volume-title":"Terminology and guidelines for Glaucoma","author":"European Glaucoma Society","year":"2008","unstructured":"European Glaucoma Society: Terminology and guidelines for Glaucoma. 2008, Savona: Dogma S.r.l, 3","edition":"3"},{"issue":"8","key":"359_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.matbio.2007.07.001","volume":"26","author":"HJ Ra","year":"2007","unstructured":"Ra HJ, Parks WC: Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007, 26 (8): 587-596. 10.1016\/j.matbio.2007.07.001.","journal-title":"Matrix Biol"},{"key":"359_CR22","first-page":"21929","volume":"265","author":"AR Mackay","year":"1990","unstructured":"Mackay AR, Hartzler JL, Pelina MD, Thorgeirsson UP: Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J BiolChem. 1990, 265: 21929-21934.","journal-title":"J BiolChem"},{"key":"359_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.20030626","volume":"198","author":"S Filippov","year":"2003","unstructured":"Filippov S, Caras I, Murray R, Matrisian LM, Chapman HA, Shapiro S, Weiss SJ: Matrilysin-dependent elastolysis by human macrophages. J Exp Med. 2003, 198: 925-935. 10.1084\/jem.20030626.","journal-title":"J Exp Med"},{"key":"359_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1350-9462(98)00011-1","volume":"18","author":"E L\u00fctjen-Drecoll","year":"1999","unstructured":"L\u00fctjen-Drecoll E: Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res. 1999, 18: 91-119. 10.1016\/S1350-9462(98)00011-1.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"359_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00055735-200004000-00004","volume":"11","author":"FA La Rosa","year":"2000","unstructured":"La Rosa FA, Lee DA: Collagen degradation in glaucoma: will it gain a therapeutic value?. Curr Opin Ophthalmol. 2000, 11 (2): 90-93. 10.1097\/00055735-200004000-00004.","journal-title":"Curr Opin Ophthalmol"},{"key":"359_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00061198-200212000-00012","volume":"11","author":"PM Puska","year":"2002","unstructured":"Puska PM: Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma\u2014a prospective 10-year follow-up study. J Glaucoma. 2002, 11: 517-524. 10.1097\/00061198-200212000-00012.","journal-title":"J Glaucoma"},{"issue":"2","key":"359_CR27","first-page":"168","volume":"17","author":"JC Tan","year":"2006","unstructured":"Tan JC, Peters DM, Kaufman PL: Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol. 2006, 17 (2): 168-174.","journal-title":"Curr Opin Ophthalmol"},{"key":"359_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s004170000252","volume":"239","author":"G Picht","year":"2001","unstructured":"Picht G, Welge-Luben U, Grehn F, Lutjen-Drecoll E: Transforming growth factor b2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001, 239: 199-207. 10.1007\/s004170000252.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"359_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00417-006-0439-7","volume":"245","author":"ET Detorakis","year":"2007","unstructured":"Detorakis ET, Achtaropoulos AK, Drakonaki EE, Kozobolis VP: Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007, 245 (4): 516-521. 10.1007\/s00417-006-0439-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"359_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00418-006-0163-8","volume":"126","author":"I Koskivirta","year":"2006","unstructured":"Koskivirta I, Rahkonen O, M\u00e4yr\u00e4np\u00e4\u00e4 M, Pakkanen S, Husheem M, Sainio A, Hakovirta H, Laine J, Jokinen E, Vuorio E, Kovanen P, J\u00e4rvel\u00e4inen H: Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem Cell Biol. 2006, 126 (3): 335-342. 10.1007\/s00418-006-0163-8.","journal-title":"Histochem Cell Biol"},{"key":"359_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/1097-4644(20010315)80:4<512::AID-JCB1005>3.0.CO;2-N","volume":"80","author":"CM Tummalapalli","year":"2001","unstructured":"Tummalapalli CM, Heath BJ, Tyagi SC: Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts. J Cell Biochem. 2001, 80: 512-521. 10.1002\/1097-4644(20010315)80:4<512::AID-JCB1005>3.0.CO;2-N.","journal-title":"J Cell Biochem"},{"issue":"20","key":"359_CR32","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.lfs.2004.07.007","volume":"75","author":"YH Guo","year":"2004","unstructured":"Guo YH, Gao W, Li Q, Li PF, Yao PY, Chen K: Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. Life Sci. 2004, 75 (20): 2483-2493. 10.1016\/j.lfs.2004.07.007.","journal-title":"Life Sci"},{"issue":"5","key":"359_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00417-006-0440-1","volume":"245","author":"S R\u00f6nkk\u00f6","year":"2007","unstructured":"R\u00f6nkk\u00f6 S, Rekonen P, Kaarniranta K, Puustj\u00e4rvi T, Ter\u00e4svirta M, Uusitalo H: Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007, 245 (5): 697-704. 10.1007\/s00417-006-0440-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"359_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.exer.2005.07.004","volume":"82","author":"AG Konstas","year":"2006","unstructured":"Konstas AG, Koliakos GG, Karabatsas CH, Liakos P, Schl\u00f6tzer-Schrehardt U, Georgiadis N, Ritch R: Latanoprost therapy reduces the levels of TGFbeta1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res. 2006, 82 (2): 319-322. 10.1016\/j.exer.2005.07.004.","journal-title":"Exp Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-13-69\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:12:50Z","timestamp":1548213170000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-13-69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-13-69","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,8]]},"article-number":"69"}}